| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | CFO & Treasurer | Common Stock | 81,405 | $729,389 | $8.96 | 05 Aug 2024 | Direct |
| Sage Therapeutics, Inc. | CFO & Treasurer | Stock Option (Right to Buy) | 22,500 | 13 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | 05 Aug 2024 | 2 | -$32,579 | 4 | CFO & Treasurer | 07 Aug 2024, 16:05 |
| SAGE | Sage Therapeutics, Inc. | 13 Feb 2024 | 2 | $0 | 4 | CFO & Treasurer | 15 Feb 2024, 17:02 |
| SAGE | Sage Therapeutics, Inc. | 02 Jan 2024 | 2 | +$2,233 | 4 | CFO & Treasurer | 04 Jan 2024, 16:07 |
| SAGE | Sage Therapeutics, Inc. | 28 Nov 2023 | 2 | -$18,172 | 4 | CFO & Treasurer | 30 Nov 2023, 16:04 |
| SAGE | Sage Therapeutics, Inc. | 15 Mar 2023 | 2 | +$4,080 | 4 | CFO & Treasurer | 17 Mar 2023, 16:09 |
| SAGE | Sage Therapeutics, Inc. | 21 Feb 2023 | 4 | +$1,360 | 4 | CFO & Treasurer | 23 Feb 2023, 17:03 |
| SAGE | Sage Therapeutics, Inc. | 13 Feb 2023 | 1 | $0 | 4 | CFO & Treasurer | 15 Feb 2023, 15:46 |
| SAGE | Sage Therapeutics, Inc. | 03 Feb 2023 | 2 | -$40,362 | 4 | CFO & Treasurer | 07 Feb 2023, 15:10 |
| SAGE | Sage Therapeutics, Inc. | 09 Jan 2023 | 2 | +$2,176 | 4 | CFO & Treasurer | 11 Jan 2023, 15:02 |
| SAGE | Sage Therapeutics, Inc. | 04 Jan 2023 | 2 | +$2,448 | 4 | CFO & Treasurer | 05 Jan 2023, 15:30 |
| SAGE | Sage Therapeutics, Inc. | 17 Feb 2022 | 2 | +$6,120 | 4 | CFO & Treasurer | 18 Feb 2022, 15:10 |
| SAGE | Sage Therapeutics, Inc. | 11 Feb 2022 | 1 | $0 | 4 | CFO & Treasurer | 15 Feb 2022, 15:42 |
| SAGE | Sage Therapeutics, Inc. | 22 Nov 2021 | 5 | +$4,760 | 4 | CFO & Treasurer | 23 Nov 2021, 16:15 |
| SAGE | Sage Therapeutics, Inc. | 19 Oct 2021 | 2 | -$41,257 | 4 | CFO & Treasurer | 21 Oct 2021, 16:04 |
| SAGE | Sage Therapeutics, Inc. | 15 Jun 2021 | 6 | -$41,534 | 4 | CFO & Treasurer | 17 Jun 2021, 09:12 |